Location: In the laboratory of Prof. Mark Prausnitz, School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA.
Duration: This position will start in Summer 2013. This position is unpaid but provides academic credit.
Qualifications: The candidate should be currently pursuing a bachelor’s degree in Chemical Engineering, Biomedical Engineering, Biochemistry or a related science program. Prior experience with working in a laboratory setting is an advantage but not required.
Background: The National Institutes of Health has awarded Georgia Tech a grant to fund development of a novel dissolving microneedle patch for influenza vaccination and bring it into a Phase I clinical trial in 2014-2015. Based on 15 years of research and 70 journal articles on microneedles, Georgia Tech has developed prototype microneedle patches and tested them extensively on animals to demonstrate influenza vaccination efficacy. Microneedles are micron-scale structures (see figure) that painlessly pierce into the skin surface, thereby depositing vaccine in the upper layers of skin. This route of administration has a number of advantages, including the possibility of self-administration and increased vaccine immunogenicity.
Job description: This position provides a unique opportunity to be part of a product development team that is developing a dissolving microneedle patch for influenza vaccination for a Phase I clinical trial. The candidate will be assisting in preparing formulations, carrying out assays for quantitative analysis of vaccine loading in patches and assessment of its stability in test prototypes. The candidate will gain knowledge and hands-on experience running various analytical assays such as ELISA and protein assays.
Contact: If interested, please send your resume and cover letter to Priya Kalluri at priya.kalluri@chbe.gatech.edu
No comments:
Post a Comment